• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Reduction in vaccination rates predicted to increase incidence and cost of measles

byJames EnglandandAnees Daud
July 28, 2017
in Infectious Disease, Pediatrics, Public Health
Reading Time: 2 mins read
African American and Hispanic youth more likely to discontinue ADHD treatment
Share on FacebookShare on Twitter

1. This study predicted an increase in the incidence of measles cases and outbreak size using a stochastic mathematical model calibrated using published cases in the United States. The increased number of cases was associated with significantly increased medical cost.

2. Elimination of non-medical exemptions to increase MMR vaccine adherence predicted there would be a reduction in the annual incidence of measles cases in the United States by 20%.

Evidence Rating Level: 3 (Average)   

Study Rundown: In recent years, misinformation regarding vaccine safety has led to declining rates of childhood vaccination in the United States through parental non-medical exemptions based on personal beliefs. Reduction in vaccination adherence is a major public health concern due to the increased risk of outbreaks of childhood illnesses. The current study sought to accurately model measles outbreaks as a function of vaccination rate using data available from the US Center for Disease Control and Prevention (CDC). Economic cost associated with increased case rates were estimated using published literature. The study found nationwide MMR vaccination rate was 93%. A 5% reduction in vaccination rate was associated with a threefold increase in the number of annual measles cases with an estimated cost of $2.1 million annually. Elimination of non-medical exemptions to vaccinations was estimated to increase MMR vaccination rates to 95% and lower measles incidence by 20%.

The main strengths of the model included the validation using data from England and Wales, and sensitivity analysis describing variation in results but an overall conservative estimate of potential costs associated with declining MMR vaccination rates. The main limitations of the results were in the reliance of population wide data with state-level variation in reporting standards for vaccine rates and disease cases, and assumptions made in the basic reproductive number associated with measles.

Click to read the study, published in JAMA Pediatrics

RELATED REPORTS

New Mexico measles outbreak associated with significant costs

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults

Relevant Reading: Measles Outbreak in a Highly Vaccinated Population, San Diego, 2008: Role of the Intentionally Undervaccinated

In-Depth [mathematical model]: This study obtained data from the US CDC and state-level reports of MMR vaccination rates from 2010-2015 and national data from 2007-2008 from representative counties to estimate vaccine rate variation. Measles outbreaks were modeled based on two chance events: imported measles cases from travelers and exposure to susceptible children, and subsequent outbreak size. The model was calibrated using data from the United States and validated using data from England and Wales. Cost per case of measles was obtained from prior literature and estimated to be $20 000.

MMR vaccination rates were estimated at 93% (87-97% state variation) with rates of non-medical exemption of 2% (0.4-6.2% state variation). In the developed model there were 48 annual cases of measles with a 5% reduction in vaccination rate estimated to increase this incidence to 150 per year. This is associated with an annual cost of $2.1 million. Eliminating non-medical exemptions was estimated to increase MMR vaccination prevalence to 95% and reduce annual incidence to 38 cases.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: measlesmumpsrubellavaccination
Previous Post

Increased neurodegenerative pathology associated with chronic traumatic encephalopathy severity

Next Post

Genetic variants related to serum calcium levels associated with coronary artery disease

RelatedReports

Epidemiologic features of the 2018-2019 measles outbreak in New York City
Infectious Disease

New Mexico measles outbreak associated with significant costs

August 2, 2026
Social networks play key roles in parental vaccination decisions
Infectious Disease

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

June 29, 2026
Cardiovascular risk factors related to brain volume and associated dementia
Neurology

Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults

June 15, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Cardiology

COVID-19 vaccination is associated with reduced risk of new-onset atrial fibrillation following COVID-19 infection

April 29, 2026
Next Post
PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Genetic variants related to serum calcium levels associated with coronary artery disease

Half of all readmissions following lower respiratory infections occur in infants

Half of all readmissions following lower respiratory infections occur in infants

Computed tomography improves diagnostic certainty in the emergency department

Chronic medical conditions linked to high emergency department use

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
  • Ecopipam reduces relapse risk in pediatric Tourette syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.